Insiders Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 11/04/2026 HKT			5-day change	1st Jan Change
238.46 ^USD	-1.18%		-1.88%	+15.23%

04-11	S&P 500 Posts Weekly Gain Ahead of Iran Peace Talks, Earnings	MT
04-11	US earnings season set to test war-rattled stocks	RE

Insiders

04-08	Hologic, Inc. Announces the Appointment of José E. Almeida as Chief Executive Officer, Effective April 7, 2026	CI
04-02	Harmony Biosciences Holdings, Inc. Announces Management Changes	CI
04-02	Orion Corporation Appoints Berkeley Vincent as Executive Vice President, Innovative Medicines and A Member of the Orion Executive Team as of 8 April 2026	CI
03-31	Sai Life Sciences Limited Announces Management Changes	CI
03-28	Cue Biopharma, Inc. Announces Chief Executive Officer Changes	CI
03-28	Cue Biopharma, Inc. Announces Management Changes	CI
03-18	Global markets live: Nvidia, Amazon, Oracle, Lululemon, Airbus…
03-17	GE HealthCare Technologies Inc. Appoints Kevin A. Lobo as Board Director, Effective March 13, 2026	CI
03-17	Firebrick Pharma Limited Appoints Nilesh Wadhwa as Head of Business Development and Licensing, Effective April 1, 2026	CI
03-09	Lyell Immunopharma, Inc. Appoints Smital Shah as Chief Business Officer and Principal Financial Officer, Effective March 9, 2026	CI
03-09	Premier Foods plc Announces Chief Customer Officer Changes	CI
03-05	Coloplast Names New CEO	MT
03-05	Coloplast A/S Announces President Changes	CI
03-05	Coloplast A/S Announces CEO Changes	CI
02-25	Artiva Biotherapeutics, Inc. Appoints Thad Huston as Principal Financial Officer and Principal Accounting Officer, Effective from February 18, 2026	CI
02-19	Johnson & Johnson Insider Sold Shares Worth $21,767,827, According to a Recent SEC Filing	MT
02-19	Johnson & Johnson Insider Sold Shares Worth $15,109,759, According to a Recent SEC Filing	MT
02-17	Integra Lifesciences Holdings Corporation Announces Appointments of Executives	CI
02-17	Cyclerion Therapeutics, Inc. Announces Formation of Clinical Advisory Board	CI
02-13	Olympus Corporation Announces Change of Executive Officer, Effective April 1, 2026	CI
02-12	Oryzon Genomics, S.A. Announces Chief Medical Officer For CNS Programs Changes	CI
02-09	NervGen Pharma Corp. Appoints Adam Rogers as President, Effective February 9, 2026	CI
02-09	Nervgen Pharma Corp. Appoints Adam Rogers as Chief Executive Officer, Effective February 9, 2026	CI
02-05	IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer	CI
02-04	Freshpet, Inc. Announces Appointment of Ana Lopez as Senior Vice President of Supply Chain, Effective February 2, 2026	CI